FBR & Co. Still Sidelined on Intercept Pharma (ICPT) Amid M&A Chatter; Sees Takeout Around $192/Share

December 16, 2015 11:55 AM

FBR & Co. is commenting on Intercept Pharma (Nasdaq: ICPT) amid recent M&A speculation. Reports out earlier in the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found